Valuation: aXichem AB

Market Cap 119M 12.15M 10.84M 9.95M 9.05M 16.97M 1.15B 17.31M 47.91M 607M 45.59M 44.62M 1.92B P/E 2024
-2.93x
P/E 2025 -6.9x
Enterprise Value 121M 12.32M 10.99M 10.09M 9.18M 17.21M 1.17B 17.55M 48.58M 615M 46.22M 45.23M 1.94B EV / Sales 2024
7.67x
EV / Sales 2025 6.72x
Free-Float
95.28%
Yield 2024 *
-
Yield 2025 -
1 day+9.40%
1 week+10.34%
Current month+9.40%
1 month+1.05%
3 months-43.20%
6 months+45.45%
Current year-7.25%
1 week 1.44
Extreme 1.44
1.93
1 month 1.44
Extreme 1.44
2
Current year 1.14
Extreme 1.135
4
1 year 1.14
Extreme 1.135
4
3 years 0.9
Extreme 0.898
12.6
5 years 0.9
Extreme 0.898
27
10 years 0.9
Extreme 0.898
95.8
Manager TitleAgeSince
Chief Executive Officer 69 2015-12-31
Chief Operating Officer 51 2025-04-15
Investor Relations Contact 64 2014-12-31
Director TitleAgeSince
Chairman 69 2007-07-05
Chairman 80 2016-12-31
Director/Board Member 77 2016-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
3/28/24 Exercice

Director

134,408 0.6253%
3/28/24 Exercice

Director

33,602 0.1563%
3/27/24 Buy

Founder

200,000 0.9304%
Change 5-day change 1-year change 3-year change Capi.($)
+9.40%+10.34%-29.93%-82.86% 12.1M
+1.99%+6.83%+19.88%+80.35% 84.98B
+0.68%+1.52%+22.93%+30.17% 44.52B
+3.15%+4.85%+22.19%-17.45% 34.88B
+1.70%+3.93%+16.33%+18.77% 34.16B
-0.11%-1.56%+19.13%+40.49% 32.15B
-0.94%+2.36%-3.07%+24.84% 26.59B
+1.60%-1.50%+56.01%+36.82% 23.93B
+1.21%+4.21%+36.43%-30.54% 18.91B
+0.31%-3.87%+12.71%+14.12% 15.61B
Average +1.84%-0.82%+17.26%+11.47% 31.57B
Weighted average by Cap. +1.22%+0.93%+21.54%+33.85%

Financials

2024 2025
Net sales 8.57M 876K 782K 718K 653K 1.22M 82.91M 1.25M 3.45M 43.76M 3.29M 3.22M 138M 18.45M 1.89M 1.68M 1.54M 1.4M 2.63M 178M 2.69M 7.44M 94.19M 7.07M 6.92M 298M
Net income -17.81M -1.82M -1.63M -1.49M -1.36M -2.54M -172M -2.59M -7.18M -90.96M -6.83M -6.69M -287M -17.63M -1.8M -1.61M -1.48M -1.34M -2.52M -171M -2.57M -7.11M -90.04M -6.76M -6.62M -284M
Net Debt -14.36M -1.47M -1.31M -1.2M -1.09M -2.05M -139M -2.09M -5.79M -73.32M -5.51M -5.39M -232M 1.64M 168K 150K 138K 125K 235K 15.9M 239K 663K 8.39M 631K 617K 26.52M
Projected Income Statement - Annual - aXichem AB
Logo aXichem AB
aXichem AB (publ) is a Sweden-based biochemical company. It develops an eco-friendly solution, Phenylcapsaicin. Phenylcapsaicin is a non-toxic antifouling agent, which can be used in the shipping industry, as it keeps vessels free from fouling. Additionally, the Company holds several world patents for alternative uses and applications of phenylcapsaicin. Phenylcapsaicin can be applied as bio-repellent against all living organisms in settings where animals cause damage to human installations. The Company’s products comprise bio-repellents, feed ingredients, food and dietary supplements, which contain synthetically produced and patented capsaicin, traded as aXiphen. The Company’s shareholders are MANAKIN LTD, BLACK ARROW LTD and LMK VENTURES AB, among others.
Employees
7
Date Price Change Volume
26-11-02 SEK 1.920 +9.40% 94,968
26-10-30 SEK 1.755 +4.15% 71,725
26-10-29 SEK 1.685 -2.88% 99,930
26-10-28 SEK 1.735 -0.29% 44,556
26-10-27 SEK 1.740 0.00% 29,009
  1. Stock Market
  2. Stocks
  3. AXIC A Stock